High-frequency tRNS for Sleep Disturbances in Neurocognitive Disorders Due to Vascular Disease
Key facts
- Who runs it
- Chinese University of Hong Kong
- Where
- Hong Kong1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 30 people enrolled
- Started
- 1 Aug 2023
- Ended
- 31 Dec 2024
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Transcranial current stimulation (tCS)
- Record updated
- 14 January 2025
Who can take part
- Age
- 60 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Chinese, right-handed, aged from 60 to 80 years
- With at least one cerebrovascular risk factor, e.g., a history of hypertension defined as systolic blood pressure (BP) 140 mm Hg or higher, diastolic BP of 90 mm Hg or higher; or receiving antihypertensive medication
- Score of Montreal Cognitive Assessment Hong Kong version (HK MoCA) range from 22 to 26 (Lu et al., 2019)
- With preserved functional abilities reflected by a Functional Assessment Questionnaire score of 7 or lower (Hajjar et al., 2020)
- With a medial temporal lobe atrophy (MTA) score < 2
- No interference with independence in everyday activities
Who cannot take part
- Previous diagnosis of dementia or stroke
- Already attending regular training, such as cognitive behavioral therapy
- Past history of bipolar disorders or psychosis
- Taking a psychotropic or other medication known to affect cognition (e.g. anti-dementia medication)
- Physically frail affecting attendance to training sessions
- Significant communicative impairments
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The investigators aim to 1) investigate and compare the safety, efficacy and sustainability of hf-tRNS, tACS and sham transcranial current stimulation (tCS) over left inferior parietal lobe (IPL) in mild neurocognitive disorder due to vascular disease (NCD-vascular) patients with sleep disturbances; 2) examine the relationship between the changes in sleep quality, cognitive function and brain morphometry.
Read full original descriptionShow less
Methods: Chinese right-handed mild NCD-AD patients with sleep disturbances (aged from 60 to 90 years) will be randomly assigned to a 2-week intervention of either hf-tRNS, tACS, or sham tCS, with 10 participants per arm. Before intervention, structural magnetic resonance imaging (MRI) data is used to construct individual realistic head model. Comprehensive assessments, including sleep quality, cognitive performance and blood pressure will be conducted at baseline, 2th week, 6th week and 12th week. Program adherence and adverse effects will be monitored throughout intervention.
The 3 groups in the trial
- High-frequency Transcranial Random Noise Stimulation (Hf-tRNS)Existing treatment, for comparison
The stimulation parameters of hf-tACS include: 20 minutes at 101-640 Hz, 2 milliamps.
Treatment: Transcranial current stimulation (tCS)
- Transcranial alternating current stimulation (tACS)Existing treatment, for comparison
The stimulation parameters of HD-tACS include: 20 minutes at 40 Hz, 2 milliamps.
Treatment: Transcranial current stimulation (tCS)
- Sham transcranial current stimulation (tCS)Sham treatment, for comparison
In sham condition, the stimulation only last for 30 seconds with the electrodes left in place for a further 20 minutes.
Treatment: Transcranial current stimulation (tCS)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- High-frequency Transcranial Random Noise Stimulation (Hf-tRNS) for Sleep Disturbances in Neurocognitive Disorders Due to Vascular Disease
- Publications
- Record updated
- 14 January 2025